?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
signalgroup
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
December 10, 2025
signalgroup
Biosimilars Forum Calls for Congress to Pass the Skinny Labels, Big Savings Act to Support Safe, Effective and Lower-Cost Biosimilars
News
October 29, 2025
signalgroup
Biosimilars Forum Applauds FDA Commissioner Dr. Marty Makary for Supporting Safe, Effective and Lower-Cost Biosimilars
News
October 29, 2025
signalgroup
The Biosimilars Forum Thanks and Commends Trump Administration Healthcare Leaders for Supporting Lower-Cost, Safe and Effective Biosimilars
News
October 7, 2025
signalgroup
The Biosimilars Forum Calls for State Policies that Support Lower-Cost Prescription Drugs Including Biosimilars for Patients that Need Them
News
May 22, 2025
signalgroup
Biosimilars Forum Submits Comments to Accelerate Safe and Effective Biosimilar Development by Modernizing the FDA and Eliminating Bureaucratic Inefficiencies
News
May 13, 2025
signalgroup
Biosimilars Forum Applauds House of Representatives Committee on Energy and Commerce for Including PBM Reform in Reconciliation Package
News
May 13, 2025
signalgroup
The Biosimilars Forum Submits Comments Highlighting Biosimilars as Safe and Effective Lower-Cost Medicines for Americans that Need Them
News
April 16, 2025
signalgroup
Biosimilars Forum Applauds the Trump Administration for Drug Pricing Executive Order
News
April 15, 2025
signalgroup
Biosimilars Forum Statement on Tariffs Impacting Low Cost Medicines
News
April 8, 2025
signalgroup
Biosimilars Forum Urges Congressional Action on Biosimilars
01
02
03
Next page